Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Summary of Direct Healthcare Professional Communications (DHPCs) issued in June 2019
Notice type:
3rd Party Publications
Date:
02/07/2019
Please find below the links to all Direct Healthcare Professional Communications (DHPCs) issued in June 2019
28/06/2019
RoActemra (tocilizumab) - Important Safety Information from Roche Products (Ireland) Ltd as approved by HPRA
28/06/2019
Febuxostat - Important Safety Information from Marketing Authorisation Holders of products containing febuxostat as approved by HPRA
27/06/2019
Darzalex (daratumumab) - Important Safety Information from Janssen Ireland as approved by HPRA
11/06/2019
Modafinil - Important Safety Information from Teva Pharmaceuticals Ireland, Clonmel Healthcare Ltd and Fannin Limited as approved by HPRA
« Back
Date Printed: 01/05/2024